medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2009, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2009; 7 (2)

Necrobiosis lipoidica

Cepeda VR, Salas AJ

Language: Spanish
References: 102
Page: 132-135
PDF size: 1071.29 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Houda H, Soumaya Y, Kahena J, Mohamed RD, Nejib D. “Per fo - rating necrobiosis lipoidica in a girl with type 1 diabetes mellitus: A new case reported”. Dermatol Online J 2008; 14 (supl. 7): 11.

  2. Wolff K, Goldsmith LA, Katz SI, Gilchrest B, Paller AS, Leffell DJ. Fitzpatrick’s Dermatology in General Medicine. Internet. 7a ed. McGraw- Hill, 2008. Cap. 152: “Diabetes Mellitus and Other Endocrine Diseases”, consultado el 12 de febrero de 2009 en http://0-www. accessmedicine.com.millenium.itesm.mx:80/content.aspx?aID= 2991346.

  3. Körber A, Dissemond J. “Necrobiosis lipidica diabeticorum”. CMAJ 2007; 177(12): 1498.

  4. Gökdemir G, Sakız D, Kö lü A. “Pyoderma gangrenosum-like presentation of ulcerative necrobiosis lipoidica: Diagnostic and therapeutic challenge”. J Turk Acad Dermatol 2008; 2(1): 82101cpdf.

  5. Arenas R. “Necrobiosis lipoídica”. Atlas. Dermatología, diagnóstico y tratamiento. 3a ed. México, 2005: pp. 195-197.

  6. Imakado S, Satomi H, Iskikawa M, Iwata M, Tsubouchi Y, Otsuka F. “Diffuse necrobiosis lipoidica diabeticorum associated with noninsulin dependent diabetes mellitus”. Clin Exp Dermatol 1998; 23(supl. 6): 271-273.

  7. Wee SA, Possick P. “Necrobiosis lipoidica”. Dermatol Online J 2004; 10(supl. 3): 18.

  8. O’Toole EA, Kennedy U, Nolan JJ, Young MM, Rogers S, Barnes L. “Necrobiosis lipoidica: Only a minority of patients have diabetes mellitus”. Br J Dermatol 1999; 140(supl. 2): 283-286.

  9. Dandona P, Freedman D, Barter S, Majew BB, Rhodes EL, Waston B. “Glycosylated haemoglobin in patients with necrobiosis lipoidica and granuloma annulare”. Clin Exp Dermatol 1981; 6(3): 299-302.

  10. Cohen O, Yaniv R, Karasik A, Trau H. “Necrobiosis lipoidica and diabetic control revisited”. Med Hypotheses 1996; 46(supl. 4): 348-350.

  11. Durupt F, Dalle S, Debarbieux S, Balme B, Ronger S, Thomas L. “Successful treatment of necrobiosis lipoidica with antimalarial agents”. Arch Dermatol 2008; 144(1): 118-119.

  12. Ullman S. Dahl MV. “Necrobiosis lipoidica. An immunofluroescence study”. Arch Dermatol 1977; 113: 1671-1673.

  13. Ngo B, Wigington G, Hayes K, Huerter C, Hillman B, Adler M, Rendell M. “Skin blood flow in necrobiosis lipoidica diabeticorum”. Int J Dermatol 2008; 47(4): 354-358.

  14. Wake N, Fang JC. “Necrobiosis lipoidica diabeticorum”. Engl J Med 2006; 355: e20.

  15. Fourati M, Marrak H, Fenniche S, Zakraoui H, Zghal M, Khayat O et al. “Necrobiosis lipoidica. Report of 4 cases and review of the literature”. Tunis Med 2003; 81(supl.6): 428-431.

  16. Palamaras I, Kench P, Thomson P, Al-Dulaimi AH, Stevens HP, RoblesW. “An unusual presentation of a common disease”. Dermatol Online J 14: 4.

  17. Requena L, Yus ES. “Panniculitis. Part I. Mostly septal panniculitis”. J Am Acad Dermatol 2001; 45: 163-183, 184-186.

  18. Ullman S, Dahl MV. “Necrobiosis lipoidica. An immunofluroescence study”. Arch Dermatol 1977; 113: 1671-1673.

  19. Fernandez-Flores A. “Necrobiosis lipoidica and cutaneous anaesthesia: Immunohistochemical study of neural fibres”. Folia Neuropathol 2008; 46(2): 154-157.

  20. Abdulla FR, Sheth PB. “A case of perforating necrobiosis lipoidica in an African American female”. Dermatol Online J 2008; 14(supl. 7): 10.

  21. Falanga V, Eaglstein WH. “Leg and foot ulcers: A clinician’s guide”. 1995; 49-52.

  22. Salomón HJ, Vila FJ, Sales MJM. “Úlceras de las EEII. Diagnóstico diferencial y guía de tratamiento”. Anales de Cirugía Cardiaca y Vascular 2001; 7(4): 253-270.

  23. Kirsner RS, Pardes JB, Eaglstein WH, Falanga V. “The clinical spectrum of lipodermatosclerosis”. J Am Acad Dermatol 1993; 28(4): 623-627.

  24. 24.Wee SA, Shupack JL. “Necrobiotic xanthogranuloma”. Dermatol Online J 2005; 11(4): 24.

  25. Gibson LE, Reizner GT, Winkelmann RK. “Necrobiosis lipoidica diabeticorum with cholesterol clefts in the differential diagnosis of necrobiotic xanthogranuloma”. J Cutan Pathol 1988; 15: 18-21.

  26. 26.Wolff K, Goldsmith LA, Katz SI, Gilchrest B, Paller AS, Leffell DJ. Fitzpatrick’s Dermatology in General Medicine. Internet. 7a ed. McGraw- Hill, 2008. Cap. 166: “Erythema Elevatum Diutinum”, consultado el 12 de febrero de 2009 en: http://0-www.accessmedicine.com. millenium.itesm.mx:80/content.aspx?aID=2967488.

  27. Macaron NC, Cohen C, Chen SC, Arbiser JL. “Gli-1 oncogene is highly expressed in granulomatous skin disorders, including sarcoidosis, granuloma annulare, and necrobiosis lipoidica diabeticorum”. Arch Dermatol 2005; 141: 259-262.

  28. Nguyen K, Washenik K, Shupack J. “Necrobiosis lipoidica diabeticorum treated with chloroquine”. J Am Acad Dermatol 2002; 46(2 supl.): S34-S36.

  29. 29.Kreuter A, Knierim C, Stücker M, Pawlak F, Rotterdam S, Altmeyer P, Gambichler T. “Fumaric acid esters in necrobiosis lipoidica: Results of a prospective noncontrolled study”. Br J Dermatol 2005; 153(4): 802-807.

  30. Cawley EP, Dingman RO. “Necrobiosis lipoidica diabeticorum: Its surgical treatment”. AMA Arch Derm Syphilol 1951; 63(6): 764-767.

  31. Moreno-Arias GA, Camps-Fresneda A. “Necrobiosis lipoidica diabeticorum treated with the pulsed dye laser”. J Cosmet Laser Ther 2001; 3: 143-146.

  32. Darvay A, Acland KM, Russell-Jones R. “Persistent ulcerated necrobiosis lipoidica responding to treatment with cyclosporin”. Br J Dermatol 1999; 141(4): 725-727.

  33. Remes K, Rönnemaa T. “Healing of chronic leg ulcers in diabetic necrobiosis lipoidica with local granulocyte-macrophage colony stimulating factor treatment”. J Diabetes Complications 1999; 13(2): 115-118.

  34. De Rie MA, Sommer A, Hoekzema R, Neumann HA. “Treatment of necrobiosis lipoidica with topical psoralen plus ultraviolet A”. Br J Dermatol 2002; 147(4): 743-747.

  35. Houda H, Soumaya Y, Kahena J, Mohamed RD, Nejib D. “Per fo - rating necrobiosis lipoidica in a girl with type 1 diabetes mellitus: A new case reported”. Dermatol Online J 2008; 14 (supl. 7): 11.

  36. Wolff K, Goldsmith LA, Katz SI, Gilchrest B, Paller AS, Leffell DJ. Fitzpatrick’s Dermatology in General Medicine. Internet. 7a ed. McGraw- Hill, 2008. Cap. 152: “Diabetes Mellitus and Other Endocrine Diseases”, consultado el 12 de febrero de 2009 en http://0-www. accessmedicine.com.millenium.itesm.mx:80/content.aspx?aID= 2991346.

  37. Körber A, Dissemond J. “Necrobiosis lipidica diabeticorum”. CMAJ 2007; 177(12): 1498.

  38. Gökdemir G, Sakız D, Kö lü A. “Pyoderma gangrenosum-like presentation of ulcerative necrobiosis lipoidica: Diagnostic and therapeutic challenge”. J Turk Acad Dermatol 2008; 2(1): 82101cpdf.

  39. Arenas R. “Necrobiosis lipoídica”. Atlas. Dermatología, diagnóstico y tratamiento. 3a ed. México, 2005: pp. 195-197.

  40. Imakado S, Satomi H, Iskikawa M, Iwata M, Tsubouchi Y, Otsuka F. “Diffuse necrobiosis lipoidica diabeticorum associated with noninsulin dependent diabetes mellitus”. Clin Exp Dermatol 1998; 23(supl. 6): 271-273.

  41. Wee SA, Possick P. “Necrobiosis lipoidica”. Dermatol Online J 2004; 10(supl. 3): 18.

  42. O’Toole EA, Kennedy U, Nolan JJ, Young MM, Rogers S, Barnes L. “Necrobiosis lipoidica: Only a minority of patients have diabetes mellitus”. Br J Dermatol 1999; 140(supl. 2): 283-286.

  43. Dandona P, Freedman D, Barter S, Majew BB, Rhodes EL, Waston B. “Glycosylated haemoglobin in patients with necrobiosis lipoidica and granuloma annulare”. Clin Exp Dermatol 1981; 6(3): 299-302.

  44. Cohen O, Yaniv R, Karasik A, Trau H. “Necrobiosis lipoidica and diabetic control revisited”. Med Hypotheses 1996; 46(supl. 4): 348-350.

  45. Durupt F, Dalle S, Debarbieux S, Balme B, Ronger S, Thomas L. “Successful treatment of necrobiosis lipoidica with antimalarial agents”. Arch Dermatol 2008; 144(1): 118-119.

  46. Ullman S. Dahl MV. “Necrobiosis lipoidica. An immunofluroescence study”. Arch Dermatol 1977; 113: 1671-1673.

  47. Ngo B, Wigington G, Hayes K, Huerter C, Hillman B, Adler M, Rendell M. “Skin blood flow in necrobiosis lipoidica diabeticorum”. Int J Dermatol 2008; 47(4): 354-358.

  48. Wake N, Fang JC. “Necrobiosis lipoidica diabeticorum”. Engl J Med 2006; 355: e20.

  49. Fourati M, Marrak H, Fenniche S, Zakraoui H, Zghal M, Khayat O et al. “Necrobiosis lipoidica. Report of 4 cases and review of the literature”. Tunis Med 2003; 81(supl.6): 428-431.

  50. Palamaras I, Kench P, Thomson P, Al-Dulaimi AH, Stevens HP, RoblesW. “An unusual presentation of a common disease”. Dermatol Online J 14: 4.

  51. Requena L, Yus ES. “Panniculitis. Part I. Mostly septal panniculitis”. J Am Acad Dermatol 2001; 45: 163-183, 184-186.

  52. Ullman S, Dahl MV. “Necrobiosis lipoidica. An immunofluroescence study”. Arch Dermatol 1977; 113: 1671-1673.

  53. Fernandez-Flores A. “Necrobiosis lipoidica and cutaneous anaesthesia: Immunohistochemical study of neural fibres”. Folia Neuropathol 2008; 46(2): 154-157.

  54. Abdulla FR, Sheth PB. “A case of perforating necrobiosis lipoidica in an African American female”. Dermatol Online J 2008; 14(supl. 7): 10.

  55. Falanga V, Eaglstein WH. “Leg and foot ulcers: A clinician’s guide”. 1995; 49-52.

  56. Salomón HJ, Vila FJ, Sales MJM. “Úlceras de las EEII. Diagnóstico diferencial y guía de tratamiento”. Anales de Cirugía Cardiaca y Vascular 2001; 7(4): 253-270.

  57. Kirsner RS, Pardes JB, Eaglstein WH, Falanga V. “The clinical spectrum of lipodermatosclerosis”. J Am Acad Dermatol 1993; 28(4): 623-627.

  58. 24.Wee SA, Shupack JL. “Necrobiotic xanthogranuloma”. Dermatol Online J 2005; 11(4): 24.

  59. Gibson LE, Reizner GT, Winkelmann RK. “Necrobiosis lipoidica diabeticorum with cholesterol clefts in the differential diagnosis of necrobiotic xanthogranuloma”. J Cutan Pathol 1988; 15: 18-21.

  60. 26.Wolff K, Goldsmith LA, Katz SI, Gilchrest B, Paller AS, Leffell DJ. Fitzpatrick’s Dermatology in General Medicine. Internet. 7a ed. McGraw- Hill, 2008. Cap. 166: “Erythema Elevatum Diutinum”, consultado el 12 de febrero de 2009 en: http://0-www.accessmedicine.com. millenium.itesm.mx:80/content.aspx?aID=2967488.

  61. Macaron NC, Cohen C, Chen SC, Arbiser JL. “Gli-1 oncogene is highly expressed in granulomatous skin disorders, including sarcoidosis, granuloma annulare, and necrobiosis lipoidica diabeticorum”. Arch Dermatol 2005; 141: 259-262.

  62. Nguyen K, Washenik K, Shupack J. “Necrobiosis lipoidica diabeticorum treated with chloroquine”. J Am Acad Dermatol 2002; 46(2 supl.): S34-S36.

  63. 29.Kreuter A, Knierim C, Stücker M, Pawlak F, Rotterdam S, Altmeyer P, Gambichler T. “Fumaric acid esters in necrobiosis lipoidica: Results of a prospective noncontrolled study”. Br J Dermatol 2005; 153(4): 802-807.

  64. Cawley EP, Dingman RO. “Necrobiosis lipoidica diabeticorum: Its surgical treatment”. AMA Arch Derm Syphilol 1951; 63(6): 764-767.

  65. Moreno-Arias GA, Camps-Fresneda A. “Necrobiosis lipoidica diabeticorum treated with the pulsed dye laser”. J Cosmet Laser Ther 2001; 3: 143-146.

  66. Darvay A, Acland KM, Russell-Jones R. “Persistent ulcerated necrobiosis lipoidica responding to treatment with cyclosporin”. Br J Dermatol 1999; 141(4): 725-727.

  67. Remes K, Rönnemaa T. “Healing of chronic leg ulcers in diabetic necrobiosis lipoidica with local granulocyte-macrophage colony stimulating factor treatment”. J Diabetes Complications 1999; 13(2): 115-118.

  68. De Rie MA, Sommer A, Hoekzema R, Neumann HA. “Treatment of necrobiosis lipoidica with topical psoralen plus ultraviolet A”. Br J Dermatol 2002; 147(4): 743-747.

  69. Houda H, Soumaya Y, Kahena J, Mohamed RD, Nejib D. “Per fo - rating necrobiosis lipoidica in a girl with type 1 diabetes mellitus: A new case reported”. Dermatol Online J 2008; 14 (supl. 7): 11.

  70. Wolff K, Goldsmith LA, Katz SI, Gilchrest B, Paller AS, Leffell DJ. Fitzpatrick’s Dermatology in General Medicine. Internet. 7a ed. McGraw- Hill, 2008. Cap. 152: “Diabetes Mellitus and Other Endocrine Diseases”, consultado el 12 de febrero de 2009 en http://0-www. accessmedicine.com.millenium.itesm.mx:80/content.aspx?aID= 2991346.

  71. Körber A, Dissemond J. “Necrobiosis lipidica diabeticorum”. CMAJ 2007; 177(12): 1498.

  72. Gökdemir G, Sakız D, Kö lü A. “Pyoderma gangrenosum-like presentation of ulcerative necrobiosis lipoidica: Diagnostic and therapeutic challenge”. J Turk Acad Dermatol 2008; 2(1): 82101cpdf.

  73. Arenas R. “Necrobiosis lipoídica”. Atlas. Dermatología, diagnóstico y tratamiento. 3a ed. México, 2005: pp. 195-197.

  74. Imakado S, Satomi H, Iskikawa M, Iwata M, Tsubouchi Y, Otsuka F. “Diffuse necrobiosis lipoidica diabeticorum associated with noninsulin dependent diabetes mellitus”. Clin Exp Dermatol 1998; 23(supl. 6): 271-273.

  75. Wee SA, Possick P. “Necrobiosis lipoidica”. Dermatol Online J 2004; 10(supl. 3): 18.

  76. O’Toole EA, Kennedy U, Nolan JJ, Young MM, Rogers S, Barnes L. “Necrobiosis lipoidica: Only a minority of patients have diabetes mellitus”. Br J Dermatol 1999; 140(supl. 2): 283-286.

  77. Dandona P, Freedman D, Barter S, Majew BB, Rhodes EL, Waston B. “Glycosylated haemoglobin in patients with necrobiosis lipoidica and granuloma annulare”. Clin Exp Dermatol 1981; 6(3): 299-302.

  78. Cohen O, Yaniv R, Karasik A, Trau H. “Necrobiosis lipoidica and diabetic control revisited”. Med Hypotheses 1996; 46(supl. 4): 348-350.

  79. Durupt F, Dalle S, Debarbieux S, Balme B, Ronger S, Thomas L. “Successful treatment of necrobiosis lipoidica with antimalarial agents”. Arch Dermatol 2008; 144(1): 118-119.

  80. Ullman S. Dahl MV. “Necrobiosis lipoidica. An immunofluroescence study”. Arch Dermatol 1977; 113: 1671-1673.

  81. Ngo B, Wigington G, Hayes K, Huerter C, Hillman B, Adler M, Rendell M. “Skin blood flow in necrobiosis lipoidica diabeticorum”. Int J Dermatol 2008; 47(4): 354-358.

  82. Wake N, Fang JC. “Necrobiosis lipoidica diabeticorum”. Engl J Med 2006; 355: e20.

  83. Fourati M, Marrak H, Fenniche S, Zakraoui H, Zghal M, Khayat O et al. “Necrobiosis lipoidica. Report of 4 cases and review of the literature”. Tunis Med 2003; 81(supl.6): 428-431.

  84. Palamaras I, Kench P, Thomson P, Al-Dulaimi AH, Stevens HP, RoblesW. “An unusual presentation of a common disease”. Dermatol Online J 14: 4.

  85. Requena L, Yus ES. “Panniculitis. Part I. Mostly septal panniculitis”. J Am Acad Dermatol 2001; 45: 163-183, 184-186.

  86. Ullman S, Dahl MV. “Necrobiosis lipoidica. An immunofluroescence study”. Arch Dermatol 1977; 113: 1671-1673.

  87. Fernandez-Flores A. “Necrobiosis lipoidica and cutaneous anaesthesia: Immunohistochemical study of neural fibres”. Folia Neuropathol 2008; 46(2): 154-157.

  88. Abdulla FR, Sheth PB. “A case of perforating necrobiosis lipoidica in an African American female”. Dermatol Online J 2008; 14(supl. 7): 10.

  89. Falanga V, Eaglstein WH. “Leg and foot ulcers: A clinician’s guide”. 1995; 49-52.

  90. Salomón HJ, Vila FJ, Sales MJM. “Úlceras de las EEII. Diagnóstico diferencial y guía de tratamiento”. Anales de Cirugía Cardiaca y Vascular 2001; 7(4): 253-270.

  91. Kirsner RS, Pardes JB, Eaglstein WH, Falanga V. “The clinical spectrum of lipodermatosclerosis”. J Am Acad Dermatol 1993; 28(4): 623-627.

  92. 24.Wee SA, Shupack JL. “Necrobiotic xanthogranuloma”. Dermatol Online J 2005; 11(4): 24.

  93. Gibson LE, Reizner GT, Winkelmann RK. “Necrobiosis lipoidica diabeticorum with cholesterol clefts in the differential diagnosis of necrobiotic xanthogranuloma”. J Cutan Pathol 1988; 15: 18-21.

  94. 26.Wolff K, Goldsmith LA, Katz SI, Gilchrest B, Paller AS, Leffell DJ. Fitzpatrick’s Dermatology in General Medicine. Internet. 7a ed. McGraw- Hill, 2008. Cap. 166: “Erythema Elevatum Diutinum”, consultado el 12 de febrero de 2009 en: http://0-www.accessmedicine.com. millenium.itesm.mx:80/content.aspx?aID=2967488.

  95. Macaron NC, Cohen C, Chen SC, Arbiser JL. “Gli-1 oncogene is highly expressed in granulomatous skin disorders, including sarcoidosis, granuloma annulare, and necrobiosis lipoidica diabeticorum”. Arch Dermatol 2005; 141: 259-262.

  96. Nguyen K, Washenik K, Shupack J. “Necrobiosis lipoidica diabeticorum treated with chloroquine”. J Am Acad Dermatol 2002; 46(2 supl.): S34-S36.

  97. 29.Kreuter A, Knierim C, Stücker M, Pawlak F, Rotterdam S, Altmeyer P, Gambichler T. “Fumaric acid esters in necrobiosis lipoidica: Results of a prospective noncontrolled study”. Br J Dermatol 2005; 153(4): 802-807.

  98. Cawley EP, Dingman RO. “Necrobiosis lipoidica diabeticorum: Its surgical treatment”. AMA Arch Derm Syphilol 1951; 63(6): 764-767.

  99. Moreno-Arias GA, Camps-Fresneda A. “Necrobiosis lipoidica diabeticorum treated with the pulsed dye laser”. J Cosmet Laser Ther 2001; 3: 143-146.

  100. Darvay A, Acland KM, Russell-Jones R. “Persistent ulcerated necrobiosis lipoidica responding to treatment with cyclosporin”. Br J Dermatol 1999; 141(4): 725-727.

  101. Remes K, Rönnemaa T. “Healing of chronic leg ulcers in diabetic necrobiosis lipoidica with local granulocyte-macrophage colony stimulating factor treatment”. J Diabetes Complications 1999; 13(2): 115-118.

  102. De Rie MA, Sommer A, Hoekzema R, Neumann HA. “Treatment of necrobiosis lipoidica with topical psoralen plus ultraviolet A”. Br J Dermatol 2002; 147(4): 743-747.




2020     |     www.medigraphic.com